Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile Infection

被引：85

作者：

Gould, Carolyn V. ^{[1
]}

Edwards, Jonathan R. ^{[1
]}

Cohen, Jessica ^{[1
]}

Bamberg, Wendy M. ^{[2
]}

Clark, Leigh Ann ^{[3
]}

Farley, Monica M. ^{[3
,4
,5
]}

Johnston, Helen ^{[2
]}

Nadle, Joelle ^{[6
]}

Winston, Lisa ^{[7
]}

Gerding, Dale N. ^{[8
,9
]}

McDonald, L. Clifford ^{[1
]}

Lessa, Fernanda C. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA

[2] Colorado Dept Hlth, Denver, CO 80220 USA

[3] Georgia Emerging Infect Program, Atlanta, GA USA

[4] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA

[5] Atlanta VA Med Ctr, Atlanta, GA USA

[6] Calif Emerging Infect Program, Oakland, CA USA

[7] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA

[8] Hines VA Hosp, Maywood, IL USA

[9] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA

来源：

CLINICAL INFECTIOUS DISEASES | 2013年 / 57卷 / 09期

关键词：

Clostridium difficile; clinical laboratory techniques; nucleic acid amplification techniques; incidence; surveillance; REAL-TIME PCR; ENZYME-IMMUNOASSAY; DIAGNOSIS; IMPACT; TOXIN; ASSAY;

D O I：

10.1093/cid/cit492

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

引用

页码：1304 / 1307

页数：4

共 17 条

[1] Loop-Mediated Isothermal Amplification Compared to Real-Time PCR and Enzyme Immunoassay for Toxigenic Clostridium difficile Detection [J].

Boyanton, Bobby L., Jr. ;

Sural, Preethi ;

Loomis, Caroline R. ;

Pesta, Christine ;

Gonzalez-Krellwitz, Laura ;

Robinson-Dunn, Barbara ;

Riska, Paul .

JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (03) :640-645

[2]

Centers for Disease Control and Prevention, Emerging infections program healthcare-associated infections-community interface report, Clostridioides difficile infection surveillance, 2021

[3] Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes [J].

de Jong, E. ;

de Jong, A. S. ;

Bartels, C. J. M. ;

van der Rijt-van den Biggelaar, C. ;

Melchers, W. J. G. ;

Sturm, P. D. J. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (09) :2219-2225

[4]

Dudeck MA., 2013, Risk Adjustment for Healthcare Facility-Onset C. difficile and MRSA Bacteremia Laboratory-identified Event Reporting in NHSN

[5]

Federal Register, FED REG, V76

[6] Public Reporting of Clostridium difficile and Improvements in Diagnostic Tests [J].

Goldenberg, Simon D. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (12) :1231-1232

[7] Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity [J].

Humphries, Romney M. ;

Uslan, Daniel Z. ;

Rubin, Zachary .

JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (03) :869-873

[8] Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea [J].

Johnson, Steven W. ;

Kanatani, Meganne ;

Humphries, Romney M. ;

Uslan, Daniel Z. .

AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (04) :373-375

[9]

Kandelaki G, 2011, INFECT CONT HOSP EP, V32, P932, DOI [10.1086/661788, 10.1086/661789]

[10] Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program [J].

Longtin, Yves ;

Trottier, Sylvie ;

Brochu, Gilles ;

Paquet-Bolduc, Bianka ;

Garenc, Christophe ;

Loungnarath, Vilayvong ;

Beaulieu, Catherine ;

Goulet, Danielle ;

Longtin, Jean .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (01) :67-73

← 1 2 →